PROCRIT (Janssen Products, LP)


Welcome to the PulseAid listing for the PROCRIT drug offered from Janssen Products, LP. This Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Janssen Products, LP
NON-PROPRIETARY NAME: Erythropoietin
SUBSTANCE NAME: ERYTHROPOIETIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 1989-06-01
END MARKETING DATE: 0000-00-00


PROCRIT HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPROCRIT from Janssen Products, LP
LABELER NAME: Janssen Products, LP
DEA SCHEDULE:
ACTIVE STRENGTH: 2000([iU]/mL)
START MARKETING DATE: 1989-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 59676-302_c4e1fe65-8d28-441e-9720-1b674259aefc
PRODUCT NDC: 59676-302
APPLICATION NUMBER: BLA103234

Other ERYTHROPOIETIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amgen IncEPOGEN
Janssen Products, LPPROCRIT
Physicians Total Care, Inc.PROCRIT